Johnson & Johnson
New York Stock ExchangeTotal Valuation
Johnson & Johnson carries a market capitalization of 663.28B, placing it among publicly traded companies globally. Its enterprise value stands at 639.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 663.28B |
| Enterprise Value | 639.90B |
Share Statistics
Johnson & Johnson currently has 2.41B shares outstanding.
| Shares Outstanding | 2.41B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Johnson & Johnson trades at a trailing price-to-earnings ratio of 29.07. The price-to-sales ratio is 6.25, and the price-to-book ratio stands at 7.20.
| PE Ratio | 29.07 |
| PS Ratio | 6.25 |
| PB Ratio | 7.20 |
| P/TBV Ratio | -52.11 |
| P/FCF Ratio | 18.77 |
| P/OCF Ratio | 22.15 |
Enterprise Valuation
On an enterprise value basis, Johnson & Johnson trades at an EV/EBITDA multiple of 18.82 and an EV/FCF ratio of 18.91. The EV/Sales ratio of 6.53 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.37 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.53 |
| EV / EBITDA | 18.82 |
| EV / EBIT | 24.37 |
| EV / FCF | 18.91 |
Financial Position
Johnson & Johnson maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 57.71, indicating elevated leverage, while an interest coverage ratio of 33.60 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.09 |
| Quick Ratio | 0.73 |
| Debt / Equity | 57.71 |
| Debt / EBITDA | 1.44 |
| Interest Coverage | 33.60 |
Financial Efficiency
Johnson & Johnson posts a return on equity of 25.74 and a return on invested capital of 16.51.
| Return on Equity (ROE) | 25.74 |
| Return on Assets (ROA) | 10.67 |
| Return on Invested Capital (ROIC) | 16.51 |
| Return on Capital Employed (ROCE) | 16.63 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.20 |
Taxes
Over the trailing twelve months, Johnson & Johnson has paid 4.16B in income taxes, reflecting an effective tax rate of 16.51.
| Income Tax | 4.16B |
| Effective Tax Rate | 16.51 |
Stock Price Statistics
Johnson & Johnson's stock has gained approximately 53.96621% over the past 52 weeks. The 50-day moving average sits at 261.16, while the 200-day moving average is 235.45.
| Beta (5Y) | N/A |
| 52-Week Price Change | 53.96621% |
| 50-Day Moving Average | 261.16 |
| 200-Day Moving Average | 235.45 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Johnson & Johnson generated 97.93B in revenue and converted that into 21.04B in net income, yielding earnings per share of 8.63. EBITDA reached 34.01B, while operating income came in at 26.26B.
| Revenue | 97.93B |
| Gross Profit | 66.50B |
| Operating Income | 26.26B |
| Pretax Income | 25.20B |
| Net Income | 21.04B |
| EBITDA | 34.01B |
| EBIT | 26.26B |
| Earnings Per Share (EPS) | 8.63 |
Balance Sheet
Johnson & Johnson holds 20.76B in cash and equivalents against 49.04B in total debt, resulting in a net debt position of 28.61B. Total book value stands at 84.97B, with working capital of 4.88B providing operational flexibility.
| Cash & Cash Equivalents | 20.76B |
| Total Debt | 49.04B |
| Net Debt | 28.61B |
| Equity (Book Value) | 84.97B |
| Book Value Per Share | 35.28 |
| Working Capital | 4.88B |
Cash Flow
Johnson & Johnson produced 27.61B in operating cash flow over the past twelve months. After subtracting -5.38B in capital expenditures, free cash flow totaled 22.23B - equivalent to 9.23 per share.
| Operating Cash Flow | 27.61B |
| Capital Expenditures | -5.38B |
| Free Cash Flow | 22.23B |
| FCF Per Share | 9.23 |
Margins
Johnson & Johnson operates with a gross margin of 67.91, reflecting its pricing power and cost economics. The operating margin of 26.81 and net profit margin of 21.48 provide insight into operational efficiency.
| Gross Margin | 67.91 |
| Operating Margin | 26.81 |
| Pretax Margin | 25.73 |
| Profit Margin | 21.48 |
| EBITDA Margin | 34.73 |
Dividends & Yields
The company's payout ratio of 59.99 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 5.24 |
| Dividend Yield | N/A |
| Payout Ratio | 59.99 |
| Shareholder Yield | 3.03 |
| FCF Yield | 5.33 |
Stock Splits
Johnson & Johnson's most recent stock split took place on June 13, 2001 with a 1:2 split ratio.
| Last Split Date | 6/13/2001 |
| Split Ratio | 1:2 |
Scores
Johnson & Johnson posts an Altman Z-Score of 4.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.99 |